CLINICAL_TRIALS
trial_result
· 2021-03-30
Clinical Trial Update: Liraglutide in Newly Onset Type 1 Diabetes. [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial investigating liraglutide for newly diagnosed type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hvidovre University Hospital | Conditions: Diabetes Mellitus, Type 1 | Phase 2, Phase 3 | Status: COMPLETED